New Key Statistics Module, Z-Score and F-Score
SZSE:300485 Key Ratios
Market Cap ¥ M | 3,058.58 |
Enterprise Value ¥ M | 1,832.02 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.94 |
Price/Sales | 6.82 |
Price/Free Cash Flow | 352.78 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 453.00 |
EPS (TTM) ¥ | -0.19 |
Beneish M-Score | -3.03 |
10-y EBITDA Growth Rate % | -20.70 |
5-y EBITDA Growth Rate % | -42.90 |
y-y EBITDA Growth Rate % | -466.70 |
EV-to-EBIT | -49.69 |
EV-to-EBITDA | -49.69 |
PEG | -- |
Shares Outstanding M | 481.67 |
Net Margin (%) | -19.52 |
Operating Margin % | -8.13 |
Pre-tax Margin (%) | -23.23 |
Quick Ratio | 19.26 |
Current Ratio | 20.88 |
ROA % (ttm) | -2.45 |
ROE % (ttm) | -2.58 |
ROIC % (ttm) | -1.39 |
Dividend Yield % | 0.34 |
Altman Z-Score | 14.55 |
SZSE:300485 Number of Guru Trades
SZSE:300485 Volume of Guru Trades
Gurus Latest Trades with SZSE:300485
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300485 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beijing Science Sun Pharmaceutical Co Ltd Insider Transactions
No Available Data